Up-regulated circular RNAs in colorectal cancer: New entities for therapy and tools for identification of therapeutic targets

UH Weidle, A Nopora - Cancer Genomics & Proteomics, 2023 - cgp.iiarjournals.org
Patients with disseminated colorectal cancer have a dismal prognosis with a 5-year survival
rate of only 13%. In order to identify new treatment modalities and new targets, we searched …

CircRNAs as new therapeutic entities and tools for target identification in Acute myeloid leukemia

A Nopora, UH Weidle - Cancer Genomics & Proteomics, 2024 - cgp.iiarjournals.org
Acute myeloid leukemia (AML) is a genetically extremely heterogeneous disease. Drug
resistance after induction therapy is a very frequent event resulting in poor medium survival …

Drug Discovery Targeting Post-Translational Modifications in Response to DNA Damages Induced by Space Radiation

D Xie, Q Huang, P Zhou - International Journal of Molecular Sciences, 2023 - mdpi.com
DNA damage in astronauts induced by cosmic radiation poses a major barrier to human
space exploration. Cellular responses and repair of the most lethal DNA double-strand …

Multi-omics strategy reveals that Cordyceps sinensis ameliorates sepsis-associated acute kidney injury via reprogramming of mitochondrial energy metabolism and …

L Chen, T Yang, J Wu, G Cheng, M Zhao… - Acta Materia …, 2024 - scienceopen.com
Cordyceps sinensis (CS) has been widely used as a dietary supplement or traditional
medicine for the prevention, treatment, and prognostication of various diseases, because of …

Co-delivery of PROTAC and siRNA via novel liposomes for the treatment of malignant tumors

W Zhang, Y Jin, J Wang, M Gu, Y Wang… - Journal of Colloid and …, 2025 - Elsevier
Targeted elimination of damaged or overexpressed proteins within the tumor serves a
pivotal role in regulating cellular function and restraining tumor cell growth. Researchers …

DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma

S Wei, J Xing, J Chen, L Chen, J Lv, X Chen… - Journal of Experimental …, 2024 - Springer
Background Lung cancer is a malignant tumor with the highest mortality worldwide.
Abnormalities in the ubiquitin proteasome system are considered to be contributed to lung …

Activity and resistance to KRASG12C inhibitors in non-small cell lung cancer and colorectal cancer

W Ye, X Lu, Y Qiao, WB Ou - Biochimica et Biophysica Acta (BBA)-Reviews …, 2024 - Elsevier
Non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) are associated with a
high mortality rate. Mutations in the V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog …

Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs Targeting C797S Mutation

Y Zhu, X Ye, Y Wu, H Shen, Z Cai, F Xia… - Journal of Medicinal …, 2024 - ACS Publications
The epidermal growth factor receptor (EGFR) tertiary C797S mutation is an important cause
of resistance to Osimertinib, which seriously hinders the clinical application of Osimertinib …

A Comprehensive Review of Emerging Approaches in Machine Learning for De Novo PROTAC Design

Y Gharbi, R Mercado - Digital Discovery, 2024 - pubs.rsc.org
Targeted protein degradation (TPD) is a rapidly growing field in modern drug discovery that
aims to regulate the intracellular levels of proteins by harnessing the cell's innate …

Reducing PD-L1 Expression by Degraders and Downregulators as a Novel Strategy to Target the PD-1/PD-L1 Pathway

Z Wang, L Yuan, X Liao, X Guo… - Journal of Medicinal …, 2024 - ACS Publications
Targeting the programmed cell death protein-1 (PD-1)/programmed cell death-ligand 1 (PD-
L1) pathway has evolved into one of the most promising strategies for tumor immunotherapy …